Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Calcium Plus Vitamin D Supplementation Affects Glucose Metabolism and Lipid Concentrations in Overweight and Obese Vitamin D Deficient Women With Polycystic Ovary Syndrome Publisher Pubmed



Asemi Z1 ; Foroozanfard F2 ; Hashemi T2 ; Bahmani F1 ; Jamilian M3 ; Esmaillzadeh A4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran
  2. 2. Department of Gynecology and Obstetrics, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran
  3. 3. Department of Gynecology and Obstetrics, School of Medicine, Arak University of Medical Sciences, Arak, Iran
  4. 4. Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Clinical Nutrition Published:2015


Abstract

Background & aims: Few studies have examined the effects of calcium plus vitamin D supplementation on glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome (PCOS). This study was conducted to determine the effects of calcium plus vitamin D supplementation on glucose metabolism and lipid concentrations among overweight and obese vitamin D deficient women with PCOS. Methods: This randomized double-blind placebo-controlled clinical trial was conducted among 104 overweight and obese vitamin D deficient women diagnosed with PCOS. Participants were randomly assigned into four groups to receive: 1) 1000mg/d calcium+vitamin D placebo (. n=26); 2) 50,000IU/wk vitamin D+calcium placebo (. n=26); 3) 1000mg calcium/d+50,000IU/wk vitamin D (. n=26) and 4) calcium placebo+vitamin D placebo (. n=26) for 8 weeks. Fasting blood samples were taken at baseline and after 8 weeks' intervention to measure glucose metabolism and lipid concentrations. Results: Calcium-vitamin D co-supplementation resulted in higher levels of serum calcium (. P=0.002) and vitamin D (. P<0.001) compared with other groups. Co-supplementation, compared with other groups, led to decreased serum insulin levels (. P=0.03), homeostasis model of assessment-insulin resistance (HOMA-IR) score (. P=0.04) and a significant rise in quantitative insulin sensitivity check index (QUICKI) (. P=0.001). Furthermore, a significant decrease in serum triglycerides (. P=0.02) and VLDL-cholesterol levels (. P=0.02) was seen following the administration of calcium plus vitamin D supplements compared with the other groups. Co-supplementation with calcium and vitamin D had no significant effects on FPG, total-, LDL-, HDL-, and non-HDL-cholesterol levels. Conclusions: In conclusion, calcium plus vitamin D supplementation for eight weeks among vitamin D deficient women with PCOS had beneficial effects on serum insulin levels, HOMA-IR, QUICKI, serum triglycerides and VLDL-cholesterol levels, but it did not affect FPG and other lipid profiles.Clinical registration number. www.irct.ir: IRCT201309275623N10. © 2014 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism.
Experts (# of related papers)
Other Related Docs
9. Cardiometabolic Risk Factors in Polycystic Ovary Syndrome, Pakistan Journal of Medical Sciences (2012)
18. The Effects of Oral Vitamin D on Insulin Resistance in Pre-Diabetic Patients, Journal of Research in Medical Sciences (2013)
40. Chromium Supplementation and Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis, Journal of Trace Elements in Medicine and Biology (2017)